These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19695099)

  • 21. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
    Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
    Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy.
    Scuteri L; Rordorf R; Marsan NA; Landolina M; Magrini G; Klersy C; Frattini F; Petracci B; Vicentini A; Campana C; Tavazzi L; Ghio S
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1040-9. PubMed ID: 19659624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-pro-BNP during isotonic and isometric exercise in heart failure patients with preserved LV ejection fraction.
    Zdrenghea DT; Ilea M; Bodizs G; Sitar-Tăut A; Zdrenghea M; Pop D
    Clin Lab; 2014; 60(12):2055-61. PubMed ID: 25651741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction.
    Henzler T; Roeger S; Meyer M; Schoepf UJ; Nance JW; Haghi D; Kaminski WE; Neumaier M; Schoenberg SO; Fink C
    Eur Respir J; 2012 Apr; 39(4):919-26. PubMed ID: 21965223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    Yokoyama Y; Kataoka N; Nakai M; Matsuo A; Fujiwara A; Wakamiya A; Ueda N; Nakajima K; Kamakura T; Wada M; Yamagata K; Ishibashi K; Inoue Y; Miyamoto K; Nagase S; Noda T; Aiba T; Takahama H; Izumi C; Kinugawa K; Minamino N; Kusano K
    J Cardiol; 2022 Jun; 79(6):727-733. PubMed ID: 35016810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
    Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
    Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
    Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
    Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide levels in patients with anomalous left coronary artery from pulmonary artery.
    Yunfei L; Qiang F; Yue W; Yongjun Q
    J Cardiothorac Surg; 2020 Jan; 15(1):15. PubMed ID: 31931857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction.
    Gierula J; Cubbon RM; Jamil HA; Byrom R; Baxter PD; Pavitt S; Gilthorpe MS; Hewison J; Kearney MT; Witte KK
    Europace; 2013 Nov; 15(11):1609-14. PubMed ID: 23736807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The change in NT-pro-BNP and post-PTMC echocardiography parameters in patients with mitral stenosis. A pilot study.
    Safi M; Bayat F; Ahmadi Z; Shekarchizadeh M; Khaheshi I; Naderian M
    Rom J Intern Med; 2017 Jun; 55(2):75-81. PubMed ID: 28103203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
    Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
    Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
    Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cardiac resynchronization therapy on broad neurohormone biomarkers in heart failure.
    Dong YX; Burnett JC; Chen HH; Sandberg S; Yang YZ; Zhang Y; Chen PS; Cha YM
    J Interv Card Electrophysiol; 2011 Apr; 30(3):241-9. PubMed ID: 21336616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.
    Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
    Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
    Fuat A; Murphy JJ; Hungin AP; Curry J; Mehrzad AA; Hetherington A; Johnston JI; Smellie WS; Duffy V; Cawley P
    Br J Gen Pract; 2006 May; 56(526):327-33. PubMed ID: 16638247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.